Literature DB >> 6197507

Some effects of chronic antidepressant treatments on rat brain monoaminergic systems.

M F Sugrue.   

Abstract

A range of established and putative antidepressant therapies were studied for the effect of their long-term administration on two facets of presynaptic monoaminergic functioning in rat brain, namely NE, DA, and 5-HT turnover and alpha 2-adrenoceptor sensitivity. Unless stated otherwise drugs (10 mg/kg) were injected i.p. twice daily for 14 days. ECT (100 mA for 1 s) was applied once daily for 10 days. Changes in turnover were indirectly assessed by measuring levels of metabolites. Brain levels of MHPG-SO4 were unchanged by chronic amitriptyline, imipramine, nisoxetine (20 mg/kg), nortriptyline, salbutamol (5 mg/kg), and ECT. Amitriptyline elicited a slight, but significant, increase in brain DOPAC content. Brain levels of 5-HIAA were increased by amitriptyline, imipramine, salbutamol, and ECT. An overall view of the results indicates that no common pattern of change was elicited by the range of antidepressant therapies studied. Central alpha 2-adrenoceptor sensitivity was assessed by investigating the effect of various therapies on the ability of clonidine (25 mg/kg i.p.) to decrease rat brain MHPG-SO4 content. The clonidine-induced fall was attenuated by desipramine, imipramine, and ECT. Amitriptyline, iprindole, mianserin, nisoxetine, nortriptyline, Org 6582 (10 mg/kg once daily), pargyline (25 mg/kg once daily), salbutamol, and trazodone were ineffective. The following chronic antidepressant therapies were investigated for their effect on rat frontal cortex 3H-clonidine binding: amitriptyline, desipramine, imipramine, iprindole, mianserin, nisoxetine, nortriptyline, pargyline, salbutamol, and ECT. CHronic, but not acute, pargyline decreased 3H-clonidine binding and this was due to a diminished number of binding sites. The induction of subsensitive presynaptic alpha 2-adrenoceptors in rat brain is not a property common to all forms of antidepressant therapies. Hence it cannot be the fundamental mode of action of antidepressants. No correlation exists between the changes in rat cortical 3H-clonidine binding and the observed changes in the sensitivity of central presynaptic alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197507     DOI: 10.1007/bf01248999

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  46 in total

1.  Beta adrenergic receptor binding in membrane preparations from mammalian brain.

Authors:  D B Bylund; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

2.  Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs.

Authors:  A Delini-Stula; P Baumann; O Büch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

3.  Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain--I. Metabolic studies.

Authors:  U Lebrecht; J Z Nowak
Journal:  Neuropharmacology       Date:  1980-11       Impact factor: 5.250

4.  Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines.

Authors:  K Modigh
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

5.  Supersensitivity of central noradrenergic presynaptic autoreceptors following chronic treatment with the antidepressant mianserin.

Authors:  F Cerrito; M Raiteri
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

6.  Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'-monophosphate systems in rat brain.

Authors:  R M Cohen; R P Ebstein; J W Daly; D L Murphy
Journal:  J Neurosci       Date:  1982-11       Impact factor: 6.167

Review 7.  Presynaptic noradrenergic regulation during depression and antidepressant drug treatment.

Authors:  R M Cohen; I C Campbell; M R Cohen; T Torda; D Pickar; L J Siever; D L Murphy
Journal:  Psychiatry Res       Date:  1980-09       Impact factor: 3.222

8.  Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.

Authors:  W Daniel; A Adamus; M Melzacka; J Szymura; J Vetulani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

9.  Increased brain serotonergic and noradrenergic activity after repeated systemic administration of the beta-2 adrenoceptor agonist salbutamol, a putative antidepressant drug.

Authors:  H Hallberg; O Almgren; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.

Authors:  B A McMillen; W Warnack; D C German; P A Shore
Journal:  Eur J Pharmacol       Date:  1980-02-08       Impact factor: 4.432

View more
  13 in total

1.  Changes in the amount and distribution of neuronal alkaline and acid phosphatase after chronic exposure of cultures of cingulate cortex to antidepressant drugs.

Authors:  A K Bal; M M Bird
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.

Authors:  D J McManus; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Proceedings of the British Pharmacological Society. Liverpool, 6th-8th April, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

5.  Electroconvulsive shock does not modify striatal contents of dopamine in MPTP-treated mice.

Authors:  E Garcia; J Sotelo
Journal:  Neurochem Res       Date:  1993-05       Impact factor: 3.996

6.  Effects of combined administration of L-tryptophan and tricyclic antidepressants on alpha 2- and beta-adrenoceptors and monoamine levels in rat brain.

Authors:  V A Russell; M C Lamm; A S de Villiers; J J Taljaard; D O Chalton
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

7.  Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Determination of the role of noradrenergic and 5-hydroxytryptaminergic neurones in postsynaptic alpha 2-adrenoceptor desensitization by desipramine and ECS.

Authors:  D J Heal; M R Prow; W R Buckett
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride.

Authors:  D J Heal; M R Prow; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.

Authors:  L Rényi
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.